A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise
Clinical trial NCT01095653 · COMPLETED
Trial details
- NCT number
- NCT01095653
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2012-03-01
- Enrollment
- 1179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.